What is the recommended first‑line management for typical blepharitis?

Blepharitis Treatment

First-Line Management: Warm Compresses and Eyelid Hygiene

Begin all blepharitis patients with daily warm compresses and eyelid hygiene, performed once or twice daily, as this forms the foundation of treatment regardless of blepharitis subtype. 1, 2

Warm Compress Technique

• Apply warm compresses to closed eyelids for several minutes once or twice daily using hot tap water on a clean washcloth, over-the-counter heat packs, or microwaveable bean/rice bags 2
• Ensure compresses are warm enough to soften crusts and liquefy meibomian secretions but not hot enough to burn the skin 1, 2
• This is particularly effective for posterior blepharitis/meibomian gland dysfunction (MGD) 2

Eyelid Cleansing Protocol

• Gently rub the base of eyelashes using diluted baby shampoo or commercially available eyelid cleaners on a cotton ball, cotton swab, pad, or clean fingertip 1, 2
• Hypochlorous acid 0.01% eye cleaners provide strong antimicrobial effects for both anterior and posterior blepharitis 2
• For MGD, perform vertical eyelid massage to express meibomian gland secretions after warming 2
• Rubbing the eyelid margins from side to side removes crusting from the eyelashes 1

Critical Patient Counseling Points

• This regimen must be maintained daily or several times weekly long-term, as blepharitis is chronic and symptoms recur when treatment is discontinued 1, 2
• Patients with advanced glaucoma should avoid aggressive lid pressure during massage, as this may increase intraocular pressure 2
• Patients with neurotrophic corneas require careful instruction to avoid corneal epithelial injury during cleansing 1, 2

Second-Line Treatment: Topical Antibiotics

If eyelid hygiene provides inadequate relief after 2-4 weeks, add topical antibiotic ointment to the eyelid margins. 2

Antibiotic Options

• Bacitracin or erythromycin ointment applied to eyelid margins one or more times daily or at bedtime for several weeks 1, 2
• Azithromycin in sustained-release formulation has demonstrated efficacy in reducing signs and symptoms 1, 2
• Topical tobramycin/dexamethasone suspension may reduce symptoms, though evidence comes from uncontrolled studies 1, 2

Antibiotic Stewardship

• Rotate different antibiotic classes intermittently to prevent development of resistant organisms 2
• Adjust frequency and duration based on severity and treatment response 1, 2
• Long-term antibiotic use risks creating resistant organisms 2

Third-Line Treatment: Oral Antibiotics for MGD

For MGD patients with inadequate response to eyelid hygiene and topical therapy, escalate to oral tetracyclines. 2

Oral Antibiotic Regimens

• Doxycycline, minocycline, or tetracycline given daily, then tapered after clinical improvement 2
• For women of childbearing age and children under 8 years: oral erythromycin or azithromycin 2
• Azithromycin pulse regimen: 1 g per week for 3 weeks or 500 mg daily for 3 days in three cycles with 7-day intervals 2
• Tetracyclines and macrolides provide both antimicrobial and anti-inflammatory effects 2

Demodex Blepharitis: Specific Treatment Algorithm

If collarettes are present at the base of eyelashes (pathognomonic for Demodex), initiate lotilaner 0.25% ophthalmic solution as first-line therapy. 2, 3

FDA-Approved First-Line for Demodex

• Lotilaner 0.25% ophthalmic solution applied twice daily for 6 weeks achieves mite eradication in 52-78% of patients and ≤10 collarettes in 81-93% of treated eyes 2
• Therapeutic effect is observable within 24 hours, with benefits sustained through 12 months 2
• Approximately 92% of patients rate the drops as neutral to very comfortable 2

Alternative Demodex Treatments (when lotilaner unavailable)

• Tea tree oil (TTO) 50% eyelid scrubs once weekly plus daily TTO-containing shampoo for ≥6 weeks, though efficacy is modest with mean mite counts remaining 12-13.3 after 2 months 2
• Topical ivermectin 1% cream applied to eyelashes for 15 minutes once weekly significantly improves symptoms versus eyelid hygiene alone 2
• Oral ivermectin for recalcitrant cases, though evidence is limited to case reports 2

Adjunctive Therapies

For Associated Dry Eye Disease

• Preservative-free artificial tears for patients using drops more than 4 times daily 2
• Lipid-containing supplements if MGD is present 2
• Topical perfluorohexyloctane (FDA-approved 2023) prevents tear evaporation and improves symptoms after 8 weeks 1, 2
• Preservative-free topical cyclosporine or lifitegrast for coexisting aqueous-deficient dry eye 2

Short-Term Anti-Inflammatory Therapy

• Loteprednol etabonate 0.5%/tobramycin 0.3% suspension for blepharoconjunctivitis, with lower risk of intraocular pressure rise or cataract progression compared to dexamethasone 1
• Short course of topical corticosteroids for eyelid or ocular surface inflammation, including marginal keratitis or phlyctenules 2

In-Office Procedures for Recalcitrant Cases

• Intense pulsed light (IPL) therapy yields high mite-eradication rates and improves Ocular Surface Disease Index scores, tear break-up time, and meibum quality at 30- and 60-day follow-up 2
• Use IPL with caution in Fitzpatrick skin type IV or higher due to increased melanin absorption risk 2
• Vectored thermal pulsation and microblepharoexfoliation for refractory cases 1, 2
• Physical heating and expression of meibomian glands 2

Common Pitfalls to Avoid

• Do not expect complete cure; blepharitis is chronic and requires lifelong management 1, 2
• Avoid discontinuing treatment once symptoms improve, as recurrence is inevitable without maintenance therapy 1, 2
• Do not use compresses hot enough to cause skin burns 2
• Hypochlorous acid 0.01% spray shows minimal effect on Demodex mite counts despite antimicrobial properties for general blepharitis 2
• Metronidazole exhibits poor efficacy for Demodex with mean mite counts of 9.4 (topical) and 22.0 (oral) after 2 months 2